Vés al contingut

Cercador de Publicacions

La producció científica dels nostres investigadors i investigadores és molt elevada. L'any 2022 es van publicar 1.629 articles a revistes científiques amb un factor d'impacte global que va superar els 15.000 punts.

A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction.

PMID: 28527664
Revista: JOURNAL OF HEPATOLOGY
Any: 2017
Referència: J Hepatol. 2017 Oct;67(4):669-679. doi: 10.1016/j.jhep.2017.05.010. Epub 2017 May 18.
Factor d'impacte: 12.486
Tipus de publicació: Article en revista internacional
Autors: Ni, Yi, Hommel, Mirja, Palomo, Laura, Segura, Victor, Olague, Cristina, Vales, Africa, Ruiz-Ripa, Alicia, Buti, Maria, Salido, Eduardo, Prieto, Jesus et al.
DOI: 10.1016/j.jhep.2017.05.010

A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-beta induction.

PMID: 28527664
Revista: JOURNAL OF HEPATOLOGY
Any: 2017
Referència: J Hepatol. 2017 Oct;67(4):669-679. doi: 10.1016/j.jhep.2017.05.010. Epub 2017 May 18.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Aldabe, Rafael; Buti, Maria; Di Scala, Marianna; Godoy, Cristina; Gonzalez-Aseguinolaza, Gloria; Hommel, Mirja; Ni, Yi; Olague, Cristina; Palomo, Laura; Prieto, Jesus et al.
DOI: 10.1016/j.jhep.2017.05.010

A new risk of bias checklist applicable to randomized trials, observational studies and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.

PMID: 28487158
Revista: JOURNAL OF CLINICAL EPIDEMIOLOGY
Any: 2017
Referència: J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6.
Factor d'impacte: 4.978
Tipus de publicació: Article en revista internacional
Autors: Faillie, Jean-Luc, Ferrer, Pili, Gouverneur, Amandine, Driot, Damien, Berkemeyer, Shoma, Vidal, Xavier, Martinez-Zapata, Maria Jose, Huerta, Consuelo, Rottenkolber, Marietta, Schmiedl, Sven et al.
DOI: 10.1016/j.jclinepi.2017.04.023

A new risk of bias checklist applicable to randomized trials, observational studies and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events.

PMID: 28487158
Revista: JOURNAL OF CLINICAL EPIDEMIOLOGY
Any: 2017
Referència: J Clin Epidemiol. 2017 Jun;86:168-175. doi: 10.1016/j.jclinepi.2017.04.023. Epub 2017 May 6.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Ballarin, Elena; Berkemeyer, Shoma; Castells, Xavier; Driot, Damien; Faillie, Jean-Luc; Ferrer, Pili; Gouverneur, Amandine; Huerta, Consuelo; Ibanez, Luisa; Martinez-Zapata, Maria Jose et al.
DOI: 10.1016/j.jclinepi.2017.04.023

A new two-step algorithm for the treatment of COPD.

PMID: 28179443
Revista: EUROPEAN RESPIRATORY JOURNAL
Any: 2017
Referència: Eur Respir J. 2017 Feb 8;49(2). pii: 1602200. doi: 10.1183/13993003.02200-2016. Print 2017 Feb.
Factor d'impacte: 10.569
Tipus de publicació: Carta o abstract
Autors: Miravitlles, Marc, Anzueto, Antonio et al.
DOI: 10.1183/13993003.02200-2016

A new two-step algorithm for the treatment of COPD.

PMID: 28179443
Revista: EUROPEAN RESPIRATORY JOURNAL
Any: 2017
Referència: Eur Respir J. 2017 Feb 8;49(2). pii: 1602200. doi: 10.1183/13993003.02200-2016. Print 2017 Feb.
Factor d'impacte:
Tipus de publicació: Carta o abstract
Autors: Anzueto, Antonio; Miravitlles, Marc et al.
DOI: 10.1183/13993003.02200-2016

A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.

PMID: 28084470
Revista: Scientific Reports
Any: 2017
Referència: Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461.
Factor d'impacte: 4.259
Tipus de publicació: Article en revista internacional
Autors: Rodriguez, Sarai, Raurell, Imma, Torres-Arauz, Manuel, Garcia-Lezana, Teresa, Genesca, Joan, Martell, Maria et al.
DOI: 10.1038/srep40461

A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.

PMID: 28084470
Revista: Scientific Reports
Any: 2017
Referència: Sci Rep. 2017 Jan 13;7:40461. doi: 10.1038/srep40461.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Garcia-Lezana, Teresa; Genesca, Joan; Martell, Maria; Raurell, Imma; Rodriguez, Sarai; Torres-Arauz, Manuel et al.
DOI: 10.1038/srep40461

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.

PMID: 28698276
Revista: mBio
Any: 2017
Referència: MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17.
Factor d'impacte: 6.956
Tipus de publicació: Article en revista internacional
Autors: Buzon, Maria J, Crespo, Manuel, Falco, Vicenc, Grau-Exposito, Judith, Miguel, Lucia, Navarro, Jordi, Curran, Adria, Burgos, Joaquin, Ocana, Imma, Ribera, Esteban et al.
DOI: 10.1128/mBio.00876-17

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients.

PMID: 28698276
Revista: mBio
Any: 2017
Referència: MBio. 2017 Jul 11;8(4). pii: e00876-17. doi: 10.1128/mBio.00876-17.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Badia, Rosa; Burgos, Joaquin; Buzon, Maria J; Castellvi, Josep; Crespo, Manuel; Curran, Adria; Falco, Vicenc; Grau-Exposito, Judith; Miguel, Lucia; Navarro, Jordi et al.
DOI: 10.1128/mBio.00876-17

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts.

PMID: 28546581
Revista: LEUKEMIA
Any: 2017
Referència: Leukemia. 2017 Dec;31(12):2799-2806. doi: 10.1038/leu.2017.159. Epub 2017 May 26.
Factor d'impacte: 11.702
Tipus de publicació: Article en revista internacional
Autors: Illes, A, Garcia-Manero, G, Sekeres, M A, Egyed, M, Breccia, M, Graux, C, Cavenagh, J D, Salman, H, Stauder, R, Yee, K et al.
DOI: 10.1038/leu.2017.159

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts.

PMID: 28546581
Revista: LEUKEMIA
Any: 2017
Referència: Leukemia. 2017 Dec;31(12):2799-2806. doi: 10.1038/leu.2017.159. Epub 2017 May 26.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Acharyya, S; Borbenyi, Z; Breccia, M; Cavenagh, J D; DeAngelo, D J; Egyed, M; Fenaux, P; Garcia-Manero, G; Gazi, L; Graux, C et al.
DOI: 10.1038/leu.2017.159

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

PMID: 28899363
Revista: BMC CANCER
Any: 2017
Referència: BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6.
Factor d'impacte: 3.288
Tipus de publicació: Article en revista internacional
Autors: Reynolds, Kerry Lynn, Bedard, Philippe L, Lee, Se-Hoon, Lin, Chia-Chi, Tabernero, Josep, Alsina, Maria, Cohen, Ezra, Baselga, Jose, Blumenschein, George Jr, Graham, Donna M et al.
DOI: 10.1186/s12885-017-3641-6

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.

PMID: 28899363
Revista: BMC CANCER
Any: 2017
Referència: BMC Cancer. 2017 Sep 12;17(1):646. doi: 10.1186/s12885-017-3641-6.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Alsina, Maria; Bang, Yung-Jue; Baselga, Jose; Bedard, Philippe L; Blumenschein, George Jr; Cohen, Ezra; Fernandez, Rose; Garrido-Laguna, Ignacio; Graham, Donna M; Juric, Dejan et al.
DOI: 10.1186/s12885-017-3641-6

A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.

PMID: 28592615
Revista: ONCOLOGIST
Any: 2017
Referència: Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7.
Factor d'impacte: 4.962
Tipus de publicació: Article en revista internacional
Autors: Lieu, Christopher H, Hidalgo, Manuel, Berlin, Jordan D, Ko, Andrew H, Cervantes, Andres, LoRusso, Patricia, Gerber, David E, Eder, J Paul, Eckhardt, S Gail, Kapp, Amy V et al.
DOI: 10.1634/theoncologist.2017-0175

A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS.

PMID: 28592615
Revista: ONCOLOGIST
Any: 2017
Referència: Oncologist. 2017 Sep;22(9):1024-e89. doi: 10.1634/theoncologist.2017-0175. Epub 2017 Jun 7.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Berlin, Jordan D; Cervantes, Andres; Eckhardt, S Gail; Eder, J Paul; Gerber, David E; Hidalgo, Manuel; Kapp, Amy V; Ko, Andrew H; Lieu, Christopher H; LoRusso, Patricia et al.
DOI: 10.1634/theoncologist.2017-0175

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.

PMID: 28527133
Revista: INVESTIGATIONAL NEW DRUGS
Any: 2017
Referència: Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19.
Factor d'impacte: 3.484
Tipus de publicació: Guia clínica
Autors: Almhanna, Khaldoun, Wright, David, Mercade, Teresa Macarulla, Van Laethem, Jean-Luc, Gracian, Antonio Cubillo, Guillen-Ponce, Carmen, Faris, Jason, Lopez, Carolina Muriel, Hubner, Richard A, Bendell, Johanna et al.
DOI: 10.1007/s10637-017-0473-9

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C.

PMID: 28527133
Revista: INVESTIGATIONAL NEW DRUGS
Any: 2017
Referència: Invest New Drugs. 2017 Oct;35(5):634-641. doi: 10.1007/s10637-017-0473-9. Epub 2017 May 19.
Factor d'impacte:
Tipus de publicació: Guia clínica
Autors: Almhanna, Khaldoun; Bendell, Johanna; Bols, Alain; Danaee, Hadi; Enzinger, Peter; Faris, Jason; Fasanmade, Adedigbo; Feliu, Jaime; Gracian, Antonio Cubillo; Guillen-Ponce, Carmen et al.
DOI: 10.1007/s10637-017-0473-9

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.

PMID: 28911091
Revista: ANNALS OF ONCOLOGY
Any: 2017
Referència: Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275.
Factor d'impacte: 11.855
Tipus de publicació: Article en revista internacional
Autors: Esko, V, Abdalla, K, Verma, U, Benedetti, F, Aoyama, T, Mizuguchi, H, Makris, L, Rosati, G, Elme, A, Feliu, J et al.
DOI: 10.1093/annonc/mdx275

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer.

PMID: 28911091
Revista: ANNALS OF ONCOLOGY
Any: 2017
Referència: Ann Oncol. 2017 Sep 1;28(9):2142-2148. doi: 10.1093/annonc/mdx275.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Abdalla, K; Abramov, M; Ajani, J A; Alsina, M; Aoyama, T; Benedetti, F; Bondarenko, I; Elme, A; Esko, V; Feliu, J et al.
DOI: 10.1093/annonc/mdx275

A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time.

PMID: 28216380
Revista: PREVENTIVE MEDICINE
Any: 2017
Referència: Prev Med. 2017 Jun;99:111-117. doi: 10.1016/j.ypmed.2017.02.010. Epub 2017 Feb 16.
Factor d'impacte: 3.434
Tipus de publicació: Article en revista internacional
Autors: Campins, Magda, Vilca, Luz Maria, Verma, Aman, Buckeridge, David et al.
DOI: 10.1016/j.ypmed.2017.02.010

A population-based analysis of predictors of influenza vaccination uptake in pregnant women: The effect of gestational and calendar time.

PMID: 28216380
Revista: PREVENTIVE MEDICINE
Any: 2017
Referència: Prev Med. 2017 Jun;99:111-117. doi: 10.1016/j.ypmed.2017.02.010. Epub 2017 Feb 16.
Factor d'impacte:
Tipus de publicació: Article en revista internacional
Autors: Buckeridge, David; Campins, Magda; Verma, Aman; Vilca, Luz Maria et al.
DOI: 10.1016/j.ypmed.2017.02.010

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.

PMID: 29183382
Revista: RESPIRATORY RESEARCH
Any: 2017
Referència: Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y.
Factor d'impacte: 3.841
Tipus de publicació: Revisió en revista nacional
Autors: Miravitlles, Marc, Cosio, Borja G, Arnedillo, Aurelio, Calle, Myriam, Alcazar-Navarrete, Bernardino, Gonzalez, Cruz, Esteban, Cristobal, Trigueros, Juan Antonio, Rodriguez Gonzalez-Moro, Jose Miguel, Quintano Jimenez, Jose Antonio et al.
DOI: 10.1186/s12931-017-0682-y

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.

PMID: 29183382
Revista: RESPIRATORY RESEARCH
Any: 2017
Referència: Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y.
Factor d'impacte:
Tipus de publicació: Revisió en revista nacional
Autors: Alcazar-Navarrete, Bernardino; Arnedillo, Aurelio; Baloira, Adolfo; Calle, Myriam; Cosio, Borja G; Esteban, Cristobal; Gonzalez, Cruz; Miravitlles, Marc; Quintano Jimenez, Jose Antonio; Rodriguez Gonzalez-Moro, Jose Miguel et al.
DOI: 10.1186/s12931-017-0682-y